Lexicon Pharmaceuticals (LXRX)
(Delayed Data from NSDQ)
$1.83 USD
+0.09 (5.17%)
Updated May 6, 2024 04:00 PM ET
After-Market: $1.82 -0.01 (-0.55%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.16 | 20.41% |
Earnings Summary
For their last quarter, Lexicon Pharmaceuticals (LXRX) reported earnings of -$0.20 per share, missing the Zacks Consensus Estimate of -$0.18 per share. This reflects a negative earnings surprise of 11.11%. Look out for LXRX's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year increase of 27.27%.
Earnings History
Price & Consensus
Zacks News for LXRX
All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy
LXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services